Position in IQV
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$481,604
-$147,740 QoQ
Shares Held
2,824
+1.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026HARBOR CAPITAL ADVISORS, INC. holds $14,635,869 across 10 Diagnostics & Research names. IQV ranks #8 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDNT |
RadNet, Inc.
|
105,191 | $5,879,124 | |
| 2 | VCYT |
Veracyte, Inc.
|
58,277 | $1,877,102 | |
| 3 | NEO |
Neogenomics Inc
|
243,617 | $1,807,638 | |
| 4 | TWST |
Twist Bioscience Corp
|
37,399 | $1,777,200 | |
| 5 | DGX |
Quest Diagnostics Inc
|
4,303 | $843,301 | |
| 6 | CSTL |
Castle Biosciences Inc
|
25,614 | $628,823 | |
| 7 | WGS |
GeneDx Holdings Corp.
|
9,220 | $592,108 | |
| 8 | IQV |
Iqvia Holdings Inc.
This page
|
2,824 | $481,604 |
All Filings in IQV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $481,604 | 2,824 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $629,344 | 2,792 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $530,882 | 2,795 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $428,172 | 2,717 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $481,651 | 2,732 | Shares | Sole | 2025-04-14 | |
| 2023-12-31 | $732,086 | 3,164 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $622,517 | 3,164 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $711,172 | 3,164 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $629,287 | 3,164 | Shares | Sole | 2023-04-26 | |
| No filing history on record for this holder in this stock. | ||||||